🔎 Trials Near Me

Akèy › Kolit Ulseratif › Florid › Orlando

Etid klinik pou Kolit Ulseratif nan Orlando, FL

22 etid pou Kolit Ulseratif ap chèche patisipan nan sit nan ak bò kote Orlando (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Ap rekriteFaz 2
  • Digestive And Liver Center Of Florida - Orlando /ID# 280924, Orlando
  • Clinical Research of Osceola /ID# 280593, Kissimmee · 16 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Ap rekriteFaz 4
  • Endoscopic Research, Inc., Orlando
  • Orlando Health-Orlando Regional Medical Center, Orlando
  • Digestive and Liver Center of Florida, P.A., Kissimmee · 16 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Sep 30, 2026 · NCT06581328

Confirmatory Clinical Study in Active Ulcerative Colitis

Ap rekriteFaz 2
  • Orlando Gastroenterology, P.A., Orlando
Laj 16 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07296315

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 2
  • Orlando Health Digestive Health Institute, Orlando
  • AdventHealth Orlando, Orlando
  • Novum Research, LLC, Clermont · 24 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 30, 2026 · NCT06598943

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

Ap rekriteFaz 1/2Volontè an sante akeyi
  • Xencor Investigative Site, Kissimmee · 16 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT06619990

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Ap rekriteFaz 2
  • Site 007, Kissimmee · 16 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 2
  • Site US-026, Orlando
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07845487

A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)

Ap rekriteFaz 2
  • AdventHealth Orlando ( Site 1074), Orlando
Laj 18 a 75 · Tout sèks · Mizajou Sep 28, 2026 · NCT07463183

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Ap rekriteFaz 2
  • Clinical Research of Osceola, LLC, Kissimmee · 16 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06979336

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Ap rekriteFaz 3
  • Orlando Health, Orlando
  • Digestive and Liver Center of Florida, Orlando
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937086

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

Ap rekriteFaz 2
  • Digestive and Liver Center of Florida, Orlando
  • Clinical Research of Osceola, Kissimmee · 16 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07186101

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 2
  • AdventHealth Orlando, Orlando
  • Clinical Research of Osceola, Kissimmee · 16 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Ap rekriteFaz 4
  • Endoscopic Research Inc, Orlando
Laj 18 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT06095128

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 3
  • Clinical Research of Osceola - Site Number: 8400013, Kissimmee · 16 mi lwen
Laj 16 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07185009

A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis

Ap rekriteFaz 2
  • Primary Care of Osceola, Kissimmee · 16 mi lwen
Laj 18 a 80 · Tout sèks · Mizajou Aug 21, 2026 · NCT06636656

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 3
  • Orlando Health, Inc. - Site Number: 8400084, Orlando
  • AdventHealth Orlando - Site Number: 8400070, Orlando
  • Clinical Research of Osceola - Site Number: 8400013, Kissimmee · 16 mi lwen
  • ak 1 plis
Laj 16 a 80 · Tout sèks · Mizajou Aug 20, 2026 · NCT07184996

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Ap rekrite
  • Advent Health, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT05230173

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

Ap rekriteEtid obsèvasyon
  • AdventHealth, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07237516

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

Ap rekriteEtid obsèvasyon
  • Orlando Health/Digestive Health Institute, Orlando
  • Digestive and Liver Center of Florida Kissimmee, Kissimmee · 16 mi lwen
Laj 18 a 64 · Tout sèks · Mizajou Jul 9, 2026 · NCT06398626

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

Ap rekriteFaz 2
  • Arnold Palmer Hospital - Center for Digestive Health and Nutrition, Orlando
Laj 12 a 17 · Tout sèks · Mizajou Jul 8, 2026 · NCT05287126

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Ap rekriteFaz 2
  • Mirador Therapeutics Selected Site, Orlando
Laj 18 a 80 · Tout sèks · Mizajou Mar 12, 2026 · NCT07113522

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

Ap rekrite
  • Orlando Health, Orlando
Laj 18 a 85 · Tout sèks · Mizajou Jan 8, 2026 · NCT05987852

Etid Kolit Ulseratif nan lòt vil

Lòt etid nan Orlando

Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.